Get the app
US › Healthcare

Processa Pharmaceuticals Inc (PCSA)

US · Healthcare · Biotechnology

$1.93+4.89%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-3.3M
EPS
$-1.19

Key statistics

Market cap
$5.1M
Forward P/E
0.0
P/B
2.81
Book value
$-0.11
EPS (TTM)
$-4.13
52-week high
$8.88
52-week low
$1.04
50-day MA
$1.84
200-day MA
$2.34
Beta
1.23

Analyst view

with an average price target of $25.00.

Shareholding

Insiders
14.99%
Institutions
18.25%

Largest institutional holders

FundStake
Connective Capital Management LLC3.05%
Stonepine Capital Management Llc1.97%
Geode Capital Management, LLC0.79%
Citadel Advisors Llc0.76%
XTX Topco Ltd0.48%
Jane Street Group LLC0.47%
Vanguard Capital Management, LLC0.46%
StoneX Group Inc0.41%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Processa Pharmaceuticals Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.